Mizuho raises IQVIA Holdings price target to $230

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Mizuho analyst Ann Hynes maintained an Outperform rating on IQVIA Holdings and raised the price target to $230 from $215, signaling confidence in the stock's future performance.

powered bylight_fuzz_icon
45488579

*this image is generated using AI for illustrative purposes only.

Mizuho analyst Ann Hynes has maintained an Outperform rating on IQVIA Holdings, raising the price target to $230 from $215. The adjustment reflects increased confidence in the company's performance potential.

Rating and Price Action

The research note reinforces a positive outlook for IQVIA Holdings. The revised price target of $230 represents an increase from the previous target of $215.

Metric Value
Rating Outperform
Previous Price Target $215
New Price Target $230
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors are driving the increased confidence in IQVIA's performance potential?

How might this price target adjustment influence investor sentiment toward IQVIA in the short term?

What are the key risks that could prevent IQVIA from reaching the new $230 price target?

like20
dislike

IQVIA to announce Q2FY26 results on July 28, 2026

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

IQVIA Holdings Inc. will announce its Q2FY26 financial results on July 28, 2026, before the market opens. A conference call and webcast are scheduled for 9:00 a.m. ET the same day, with registration required for participation. The earnings release and webcast replay will be available on the company's Investor Relations website.

powered bylight_fuzz_icon
45098834

*this image is generated using AI for illustrative purposes only.

IQVIA Holdings Inc. will announce its second-quarter 2026 financial results before the market opens on Tuesday, July 28, 2026. The company, a global provider of clinical research services and healthcare intelligence, will host a conference call and webcast at 9:00 a.m. Eastern Time the same day to discuss the performance. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com .

Conference Call Details

Interested parties must register in advance to participate in the conference call. Registration can be completed at http://ir.iqvia.com . Upon registration, participants will receive a confirmation email containing dial-in details, a unique passcode, and a registrant ID. Registered participants can join the call directly using the information provided in the confirmation email.

Webcast and Replay

The webcast will be accessible via the IQVIA Investor Relations website. A replay of the webcast will be available approximately two hours after the conclusion of the live event. Investors can access the recording at http://ir.iqvia.com .

Key Event Information

Event Date Time
Q2FY26 Results Announcement July 28, 2026 Before market open
Conference Call and Webcast July 28, 2026 9:00 a.m. ET
Webcast Replay Availability July 28, 2026 Approx. 2 hours post-event

IQVIA provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. The company employs approximately 93,000 people in over 100 countries.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What are the expected key financial metrics and guidance updates for the second quarter of 2026?

How might IQVIA's performance in Q2FY26 reflect broader trends in the clinical research and healthcare intelligence sectors?

What strategic initiatives or partnerships could IQVIA announce during the earnings call to drive future growth?

like19
dislike

More News on IQVIA Holdings Inc